These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 19478135)

  • 1. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
    Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
    Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
    J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD.
    Cazzola M
    Curr Opin Investig Drugs; 2009 May; 10(5):482-90. PubMed ID: 19431081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide.
    Gavaldà A; Ramos I; Carcasona C; Calama E; Otal R; Montero JL; Sentellas S; Aparici M; Vilella D; Alberti J; Beleta J; Miralpeix M
    Pulm Pharmacol Ther; 2014 Aug; 28(2):114-21. PubMed ID: 24928173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models.
    Pulido-Rios MT; McNamara A; Obedencio GP; Ji Y; Jaw-Tsai S; Martin WJ; Hegde SS
    J Pharmacol Exp Ther; 2013 Aug; 346(2):241-50. PubMed ID: 23685545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
    Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
    J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi.
    Rogliani P; Calzetta L; Ora J; Lipsi R; Segreti A; Matera MG; Cazzola M
    Eur J Pharmacol; 2015 Aug; 761():383-90. PubMed ID: 25952728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium.
    Sykes DA; Dowling MR; Leighton-Davies J; Kent TC; Fawcett L; Renard E; Trifilieff A; Charlton SJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):520-8. PubMed ID: 22854200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tiotropium as new quality medication in the COPD management].
    Lubiński W; Płusa T
    Pol Merkur Lekarski; 2006 Jan; 20(115):5-7. PubMed ID: 16617725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
    Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
    J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease.
    Vogelmeier C; Banerji D
    Ther Adv Respir Dis; 2011 Jun; 5(3):163-73. PubMed ID: 21511677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
    Maltais F; Milot J
    Ther Adv Respir Dis; 2012 Dec; 6(6):345-61. PubMed ID: 23075544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
    Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
    An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tiotropium as a controller of bronchoconstriction].
    Lubiński W
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():75-6, 78. PubMed ID: 15524023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tiotropium bromide for treating chronic obstructive pulmonary disease].
    Uteshev DB; Buniatian ND; Kovaleva VL
    Eksp Klin Farmakol; 2010 Nov; 73(11):15-8. PubMed ID: 21254592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate.
    Ogoda M; Niiya R; Koshika T; Yamada S
    J Pharmacol Sci; 2011; 115(3):374-82. PubMed ID: 21358117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety model.
    Trifilieff A; Ethell BT; Sykes DA; Watson KJ; Collingwood S; Charlton SJ; Kent TC
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):9-16. PubMed ID: 26026369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites.
    Sentellas S; Ramos I; Albertí J; Salvà M; Antón F; Miralpeix M; Beleta J; Gavaldà A
    Eur J Pharm Sci; 2010 Mar; 39(5):283-90. PubMed ID: 20093184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.